Terms: = Colorectal cancer AND PWWP2A, Q8IYR3_HUMAN, Q96N64, MST101, MGC132770, KIAA1935, ENSG00000170234, 114825 AND Clinical Outcome
276 results:
1. EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells.
Cuenca-Escalona J; Subtil B; Garcia-Perez A; Cambi A; de Vries IJM; Flórez-Grau G
Front Immunol; 2024; 15():1355769. PubMed ID: 38343540
[TBL] [Abstract] [Full Text] [Related]
2. Smartphone applications for nutrition Support: A systematic review of the target outcomes and main functionalities.
Pala D; Petrini G; Bosoni P; Larizza C; Quaglini S; Lanzola G
Int J Med Inform; 2024 Apr; 184():105351. PubMed ID: 38295584
[TBL] [Abstract] [Full Text] [Related]
3. p21 as a Predictor and Prognostic Indicator of clinical outcome in Rectal cancer Patients.
Ooi LC; Ho V; Zhu JZ; Lim S; Chung L; Abubakar A; Rutland T; Chua W; Ng W; Lee M; Morgan M; MacKenzie S; Lee CS
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255799
[TBL] [Abstract] [Full Text] [Related]
4. Nuclear pore protein POM121 regulates subcellular localization and transcriptional activity of PPARγ.
Yu Y; Farooq MS; Eberhart Meessen S; Jiang Y; Kato D; Zhan T; Weiss C; Seger R; Kang W; Zhang X; Yu J; Ebert MPA; Burgermeister E
Cell Death Dis; 2024 Jan; 15(1):7. PubMed ID: 38177114
[TBL] [Abstract] [Full Text] [Related]
5. PLA2G12A as a Novel Biomarker for colorectal cancer with Prognostic Relevance.
Parisi E; Hidalgo I; Montal R; Pallisé O; Tarragona J; Sorolla A; Novell A; Campbell K; Sorolla MA; Casali A; Salud A
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446068
[TBL] [Abstract] [Full Text] [Related]
6. α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration.
Tang Y; Thiess L; Weiler SME; Tóth M; Rose F; Merker S; Ruppert T; Schirmacher P; Breuhahn K
Cell Commun Signal; 2023 Jun; 21(1):162. PubMed ID: 37381005
[TBL] [Abstract] [Full Text] [Related]
7. Spatial resolution of cellular senescence dynamics in human colorectal liver metastasis.
Garbarino O; Lambroia L; Basso G; Marrella V; Franceschini B; Soldani C; Pasqualini F; Giuliano D; Costa G; Peano C; Barbarossa D; Annarita D; Salvati A; Terracciano L; Torzilli G; Donadon M; Faggioli F
Aging Cell; 2023 Jul; 22(7):e13853. PubMed ID: 37157887
[TBL] [Abstract] [Full Text] [Related]
8. Association of MicroRNA-652 Expression with Radiation Response of colorectal cancer: A Study from Rectal cancer Patients in a Swedish Trial of Preoperative Radiotherapy.
Pathak S; Meng WJ; Sriramulu S; Jothimani G; Jangamreddy JR; Banerjee A; Ganesan AT; Adell G; Zhang X; Sun-Zhang A; Zhang H; Sun XF
Curr Gene Ther; 2023; 23(5):356-367. PubMed ID: 37076469
[TBL] [Abstract] [Full Text] [Related]
9. EPLIN, a Putative Tumour Suppressor in colorectal cancer, Implications in Drug Resistance.
Zeng J; Sanders AJ; Ye L; Hargest R; Ruge F; Jiang WG
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499558
[TBL] [Abstract] [Full Text] [Related]
10. Enterotypical Prevotella and three novel bacterial biomarkers in preoperative stool predict the clinical outcome of colorectal cancer.
Huh JW; Kim MJ; Kim J; Lee HG; Ryoo SB; Ku JL; Jeong SY; Park KJ; Kim D; Kim JF; Park JW
Microbiome; 2022 Nov; 10(1):203. PubMed ID: 36443754
[TBL] [Abstract] [Full Text] [Related]
11. Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance.
Sui L; Zeng J; Zhao H; Ye L; Martin TA; Sanders AJ; Ruge F; Jiang A; Dou QP; Hargest R; Song X; Jiang WG
Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36382667
[TBL] [Abstract] [Full Text] [Related]
12. Insights on the potential oncogenic impact of long non-coding RNA nicotinamide nucleotide transhydrogenase antisense RNA 1 in different cancer types; integrating pathway(s) and clinical outcome(s) association.
El-Sheikh NM; Abulsoud AI; Wasfey EF; Hamdy NM
Pathol Res Pract; 2022 Dec; 240():154183. PubMed ID: 36327824
[TBL] [Abstract] [Full Text] [Related]
13. Identification of a novel prognostic signature correlated with epithelial-mesenchymal transition, N6-methyladenosine modification, and immune infiltration in colorectal cancer.
Qu X; Tan H; Mao J; Yang M; Xu J; Yan X; Wu W
Cancer Med; 2023 Mar; 12(5):5926-5938. PubMed ID: 36281556
[TBL] [Abstract] [Full Text] [Related]
14. Gut microbiota: An emerging therapeutic approach of herbal medicine for prevention of colorectal cancer.
Ying HZ; Xie W; Wang MC; He JQ; Zhang HH; Yu CH
Front Cell Infect Microbiol; 2022; 12():969526. PubMed ID: 36051242
[TBL] [Abstract] [Full Text] [Related]
15. A Systematic Pan-cancer Analysis of YY1 Aberrations and their Relationship with clinical outcome, Tumor Microenvironment, and Therapeutic Targets.
Fu X; Ji F; He Q; Qiu X
J Immunol Res; 2022; 2022():5826741. PubMed ID: 35791393
[TBL] [Abstract] [Full Text] [Related]
16. HPV status and HPV16 viral load in anal cancer and its association with clinical outcome.
Guerendiain D; Grigorescu R; Kirk A; Stevenson A; Holden MTG; Pan J; Kavanagh K; Graham SV; Cuschieri K
Cancer Med; 2022 Nov; 11(22):4193-4203. PubMed ID: 35785486
[TBL] [Abstract] [Full Text] [Related]
17. Elevated expression of the MYB proto-oncogene like 2 (MYBL2)-encoding gene as a prognostic and predictive biomarker in human cancers.
Xin Z; Li Y; Meng L; Dong L; Ren J; Men J
Math Biosci Eng; 2022 Jan; 19(2):1825-1842. PubMed ID: 35135230
[TBL] [Abstract] [Full Text] [Related]
18. B cell-related gene signature and cancer immunotherapy response.
Lundberg A; Li B; Li R
Br J Cancer; 2022 Apr; 126(6):899-906. PubMed ID: 34921229
[TBL] [Abstract] [Full Text] [Related]
19. LGR5, HES1 and ATOH1 in Young Rectal cancer Patients in Egyptian.
Morsy H; Gaballah A; Samir M; Nakundi V; Shamseya M; Mahrous H; Ghazal A; Hashish M; Arafat W
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2819-2830. PubMed ID: 34582650
[TBL] [Abstract] [Full Text] [Related]
20.
Mathew JM; Mpangase PT; Sengupta D; Kwenda S; Mavri-Damelin D; Ramsay M
Pharmacogenomics; 2021 Oct; 22(15):963-972. PubMed ID: 34528449
[No Abstract] [Full Text] [Related]
[Next]
